Checkpoint Inhibitor in the Bloodstream (IMAGE)
Caption
Checkpoint inhibitors (blue) and T-cells (brown) in the bloodstream. Immunotherapy with checkpoint inhibitors is currently used by patients with for example melanoma, lung cancer and renal cancer.
Credit
The Netherlands Cancer Institute
Usage Restrictions
The image may only be used with appropriate credit
License
Licensed content